MCMeiqi Chang

Meiqi Chang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Meiqi Chang has a total of 87 co-authors. Here are the top co-authors by number of shared publications:

  • Yu Chen

    Materdicine Lab School of Life Sciences Shanghai University Shanghai China

    19 shared publications
  • Xinran Song

    Guangzhou Key Laboratory of Medical Nanomaterials, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong‐Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat‐Sen Memorial Hospital Sun Yat‐Sen University Guangzhou China

    7 shared publications
  • Yanqiu Duan

    Science and Technology Innovation Center Shanghai Municipal Hospital of Traditional Chinese Medicine Shanghai University of Traditional Chinese Medicine Shanghai China

    5 shared publications
  • Lili Liu

    Materdicine Lab, School of Life Science Shanghai University Shanghai China

    4 shared publications
  • Chenglong Zhu

    Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China

    2 shared publications
  • Hao Fu

    Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Guangdong‐Hong Kong Joint Laboratory for RNA Medicine Guangzhou Key Laboratory of Medical Nanomaterials Medical Research Center Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

    2 shared publications

Latest Publications

  • Open Access

    Vanadium Oxide Nanoregulator Modulates cGAS‐STING Pathway‐Associated Immune Dysregulation in Sepsis

    by Tian Zhou, Ruoyu Jiang, Keyun Cao, Chenglong Zhu, Fengyan Yang, Lindong Cheng, Meiqi Chang, Yu Chen, Zui Zou

    Sepsis is driven by cytosolic accumulation of mitochondrial DNA (mtDNA) and consequent overactivation of the cGAS‐STING axis, which serves as a nodal upstream trigger for innate immune dysregulation. However, interventions directly targeting this subcellular event remain largely unexplored. To fill this gap, we synthesized a library of vanadium oxide nanostructures with distinct morphologies and identified nanospheres (VO NSs) as the optimal candidate. These VO NSs act through a multimodal mechanism, scavenging reactive oxygen species, stabilizing mitochondrial membrane potential, and blocking permeability transition pore opening, to physically constrain mtDNA egress from mitochondria, thereby ablating STING‐dependent inflammatory signaling. In murine models of sepsis, administration of VO NSs confers marked survival advantage and robust protection against multi‐organ injury. Mechanistically, using STING‐knockout mice, we demonstrate that STING ablation fully recapitulates the prophylactic efficacy of VO NSs, establishing STING as the pivotal downstream mediator. Beyond acute protection, VO NSs preserve mitochondrial genomic integrity and have the potential to disrupt the self‐reinforcing cycle between oxidative stress and immune exhaustion. This work offers an initial demonstration of a subcellular‐targeted intervention strategy for sepsis regulation, while also highlighting the potential of a modular nanoplatform for broader application in mitochondrial dysfunction‐associated diseases.

  • Nanocatalytic Inhibition of ROS‐Dependent GSDMD Palmitoylation Mitigates Sepsis Progression

    by Chenglong Zhu, Renqi Yao, Wuyang Wei, Jiaojiao Feng, Lindong Cheng, Tian Zhou, Ruoyu Jiang, Wangzheqi Zhang, Yaohua Yu, Meiqi Chang, et al.

    Sepsis is a life‐threatening condition characterized by multiple organ dysfunction, high morbidity, and mortality. Gasdermin D (GSDMD)‐mediated pyroptosis constitutes a key pathogenic mechanism. Here, we discovered that GSDMD in peripheral blood mononuclear cells (PBMCs) from septic patients undergoes enhanced palmitoylation, driven by reactive oxygen species (ROS) and mediated by ZDHHC5/ZDHHC9 transferases. Targeting this new mechanism, we designed and screened vanadium oxide hydroxide nanosheets (VOOH NSs) as catalytic ROS scavengers and GSDMD palmitoylation inhibitor. Crucially, we investigated and optimized the exposure patterns of specific lattice planes to maximize their ROS‐eliminating capability. This intervention measure prevents GSDMD palmitoylation, inhibits both canonical and non‐canonical pyroptosis, alleviates inflammatory damage, and demonstrates potent therapeutic effects in two sepsis animal models. Validation in GSDMD‐knockout mice further confirms this palmitoylation pathway as the key therapeutic target. These results demonstrate that targeting ROS‐mediated GSDMD palmitoylation is a key therapeutic strategy for treating sepsis.


  • Open Access

    Topological Quantum Biomaterials Enable Pyroptosis‐Senescence Coupling for Enhanced Colorectal Cancer Therapy

    by Zilu Chen, Kun Mei, Yan Yang, Mengna Xu, Xinyue Dai, Renjun Gu, Fuqiong Zhou, Cheng Wang, Meiqi Chang, Yan Huang, et al.

    Inducing pyroptosis in tumor cells has emerged as a promising anticancer strategy. However, under sublethal oxidative stress, a considerable fraction of cancer cells evades pyroptosis and undergoes therapy‐induced senescence, which ultimately drives chronic inflammation and facilitates tumor relapse. Here, we report an ultrasound‐responsive sequential therapeutic strategy that orchestrates the pyroptosis‐senescence axis for improved colorectal cancer therapy. This sequential therapeutic strategy integrates two functional modules, including morphologically engineered Pd 3 Sn topological quantum biomaterials and senolytic agent piperlongumine. Upon ultrasound irradiation, the tailored Pd 3 Sn nanostructures generate reactive oxygen species, which subsequently trigger zDHHC5‐mediated S‐acylation of gasdermin D, thereby initiating pyroptosis in colorectal cancer cells. Benefiting from its facet dependent near Fermi level electronic states and favorable peroxide activation kinetics, Pd 3 Sn achieves substantially improved sonocatalytic performance, allowing for the controlled production of radicals and the accurate triggering of the pyroptosis cascade. Intriguingly, the senescence‐associated secretory phenotype factors released from pyroptotic cells drive the surviving cancer cells into a senescent state. These senescent cells are then selectively eliminated by piperlongumine, effectively abrogating their senescence‐associated pro‐tumorigenic effects. In subcutaneous and liver metastasis models, this nanoplatform significantly suppresses tumor progression, achieving an 83.4% tumor volume inhibition rate and minimal liver metastatic burden. This work opens the application of quantum biomaterials in biomedicine and establishes a new therapeutic paradigm for disease treatment.

  • Open Access

    A Synergistic Sonosensitive Pyroptosis Nanoactivator for Efficient Lung Adenocarcinoma Therapy

    by Yanqiu Duan, Xinran Song, Wenting Ye, Ying Zhu, Meng Li, Lili Liu, Hao Fu, Lei Wang, Yu Chen, Meiqi Chang

    The critical challenge of apoptosis resistance severely constrains the efficacy of conventional cancer therapies. To address this issue, this study turns to pyroptosis, a lytic cell death pathway, and develops a novel therapeutic strategy by repurposing triptolide (TPL), a natural compound from traditional Chinese medicine (TCM), as a potent pyroptosis inducer. We rationally co‐load TPL with the sonosensitizer rose bengal (RB) into a customized covalent organic framework (COF) to construct a synergistic nanoplatform (CRT). The “old drug, new trick” paradigm is potentiated by a nanomaterial‐mediated synergistic mechanism: US‐triggered reactive oxygen species (ROS) generation from RB orchestrates a dual action, simultaneously inducing direct mitochondrial damage and initiating the controlled release of TPL. This dual action creates a feed‐forward loop that drives the progressive amplification of cytotoxic signals from both agents, culminating in the cooperative and robust activation of caspase‐3/GSDME‐mediated pyroptosis. Consequently, this CRT platform effectively circumvents apoptotic resistance, demonstrating tumor‐selective accumulation, potent antitumor efficacy in lung cancer models, and a highly favorable biosafety profile. This work establishes a precise and noninvasive nanomedicine paradigm, highlighting how advanced biomaterial design can unlock the synergistic potential of repurposed drugs for next‐generation cancer therapy.

  • Defect‐Regulated Hetero‐Trimetallic Nanocatalysts Augment Sonocatalytic Dynamic Therapy by Charge Transfer Facilitation and Ferroptosis Cascade Induction

    by Xinran Song, Lili Liu, Meiqi Chang, Li Ding, Yu Chen, Hao Fu

    Sonocatalytic dynamic therapy (SCDT) is an emerging non‐invasive anticancer strategy that employs ultrasound to activate sonocatalysts for the generation of reactive oxygen species (ROS). The therapeutic efficacy of this process is fundamentally governed by the intrinsic performance of the sonocatalyst. However, the artificial engineering of high‐performance ROS‐generating sonocatalysts faces significant challenges, including low catalytic efficiency, high toxicity, and off‐target accumulation. Herein, we construct the distinct two‐dimensional ultrathin hetero‐trimetallic nanocatalysts rich in oxygen vacancies for efficient SCDT against tumor. This study elucidates the critical role of multi‐metal coordination bonds and abundant defects in modulating intrinsic sonocatalytic activity. The derived trimetallic‐organic framework nanosheets, featuring uniformly dispersed iron, cobalt, and nickel hetero‐single atoms, effectively optimize the active sites, thereby providing robust sonocatalytic activity for efficient ROS generation. Furthermore, the defect‐driven sonocatalytic process mitigates the limitations of ligand‐to‐metal charge transfer, significantly enhancing the charge transfer efficiency. The consequent ROS burst acts as a redox signaling molecule that amplifies oxidative stress within the tumor microenvironment. Concurrently, ROS‐mediated intervention in the glutathione peroxidase 4 and long‐chain acyl‐CoA synthetase 4 pathways promotes the lipid peroxidation, activating the ferroptosis cascade and efficiently inhibiting tumor growth. These findings underscore the considerable prospects of defect‐rich sonocatalysts in versatile biomedical applications.

  • Iridium Nanoantidotes Attenuate Jellyfish Toxin-Induced Hepatotoxicity by Inhibiting Gasdermin D Palmitoylation

    by Lin Liu, Xiuxiu Wang, Xinran Song, Hui Huang, Xiaoyu Geng, Xue Wang, Wei Yan, Tianming Xu, Meiqi Chang, Yu Chen, et al.

    Jellyfish envenomation poses a significant clinical challenge, with Nemopilema nomurai (N. nomurai) venom capable of inducing life-threatening hepatotoxicity through mechanisms that remain poorly understood. Here, we demonstrate that its tentacle extract (TE) simultaneously triggers a reactive oxygen species (ROS) burst, activates the canonical NLRP3/Caspase-1/Gasdermin D (GSDMD) pyroptosis pathway, and induces ZDHHC9-dependent GSDMD palmitoylation, collectively contributing to hepatic injury. To counteract this dual-pathway activation, we engineered ultrasmall iridium nanoantidotes (Ir NAs) with multienzyme mimetic activities, which effectively scavenge ROS, thereby suppressing both NLRP3 inflammasome activation and GSDMD palmitoylation while preserving mitochondrial function. These nanoantidotes significantly attenuated hepatocyte pyroptosis and histopathological damage, reduced mortality in vivo, and exhibited favorable biocompatibility with rapid clearance. Our work not only identifies GSDMD palmitoylation as a critical event in jellyfish venom-induced hepatotoxicity but also presents a translatable nanotherapeutic strategy for marine envenomation and related inflammatory disorders.


  • Ischemic stroke nanomedicine

    by Lan Luo, Meiqi Chang, Ying Wang, Yu Chen, Bingcang Huang


  • A calcium manganese-based pancatalytic nanozyme as a cell pyroptosis inhibitor for efficient inflammatory bowel disease treatment

    by Lili Liu, Wenting Ye, Yanqiu Duan, Xinran Song, Li Ding, Yu Chen, Meiqi Chang

    A CaMn2O4 pancatalytic nanozyme scavenges ROS and inhibits GSDMD cleavage, and ultimately attenuates colitis by suppressing pyroptosis.


  • Open Access

    Advanced Nanomedicines for Treating Refractory Inflammation-Related Diseases

    by Xiuxiu Wang, Xinran Song, Wei Feng, Meiqi Chang, Jishun Yang, Yu Chen

    This review examines inflammation as a physiological defense mechanism against infectious agents, physical trauma, reactive oxygen species (ROS), and metabolic stress, which, under dysregulated conditions, may progress into chronic diseases. Nanomedicine, which integrates nanotechnology with medicine, suppresses inflammatory signaling pathways and overexpressed pro-inflammatory cytokines, such as ROS, to address inflammation-related pathologies. Current advances in nanomaterial design and synthesis strategies are systematically analyzed, with parallel discussions on toxicity mechanisms, influencing factors, and evaluation methods that are critical for clinical translation. Applications of functional nanomaterials are highlighted in the context of refractory inflammatory conditions, including wound healing, gastrointestinal disorders, and immune, neurological, or circulatory diseases, along with targeted delivery strategies. Persistent challenges in nanomedicine development, such as biocompatibility optimization, precise biodistribution control, and standardized toxicity assessment, are critically assessed. By bridging material innovation with therapeutic efficacy, this review establishes a framework for advancing nanomedicine to improve treatment outcomes while addressing translational barriers.